BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7677485)

  • 1. Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transfer.
    Kucharczuk JC; Elshami AA; Zhang HB; Smythe WR; Hwang HC; Tomlinson JS; Amin KM; Litzky LA; Albelda SM; Kaiser LR
    Ann Thorac Surg; 1995 Sep; 60(3):593-7; discussion 597-8. PubMed ID: 7677485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy.
    Watanabe Y; Kojima T; Kagawa S; Uno F; Hashimoto Y; Kyo S; Mizuguchi H; Tanaka N; Kawamura H; Ichimaru D; Urata Y; Fujiwara T
    Oncogene; 2010 Feb; 29(8):1145-54. PubMed ID: 19935710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
    Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
    Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma.
    Smythe WR; Kaiser LR; Hwang HC; Amin KM; Pilewski JM; Eck SJ; Wilson JM; Albelda SM
    Ann Thorac Surg; 1994 Jun; 57(6):1395-401. PubMed ID: 8010779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene.
    Elshami AA; Kucharczuk JC; Zhang HB; Smythe WR; Hwang HC; Litzky LA; Kaiser LR; Albelda SM
    Hum Gene Ther; 1996 Jan; 7(2):141-8. PubMed ID: 8788165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma.
    Sterman DH; Molnar-Kimber K; Iyengar T; Chang M; Lanuti M; Amin KM; Pierce BK; Kang E; Treat J; Recio A; Litzky L; Wilson JM; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2000 Dec; 7(12):1511-8. PubMed ID: 11228529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
    Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
    Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
    Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
    Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pleural mesothelioma-targeted CREBBP/EP300 inhibitory protein 1 promoter system for gene therapy and virotherapy.
    Fukazawa T; Matsuoka J; Naomoto Y; Maeda Y; Durbin ML; Tanaka N
    Cancer Res; 2008 Sep; 68(17):7120-9. PubMed ID: 18757427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
    Sterman DH; Recio A; Vachani A; Sun J; Cheung L; DeLong P; Amin KM; Litzky LA; Wilson JM; Kaiser LR; Albelda SM
    Clin Cancer Res; 2005 Oct; 11(20):7444-53. PubMed ID: 16243818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Asbestos and malignant pleural mesothelioma: molecular, cellular and physiopathological aspects].
    Mohr S; Keith G; Rihn B
    Bull Cancer; 2005 Nov; 92(11):959-76. PubMed ID: 16316830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats.
    Krueger T; Pan Y; Tran N; Altermatt HJ; Opitz I; Ris HB
    Lasers Surg Med; 2005 Oct; 37(4):271-7. PubMed ID: 16245295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells.
    Waheed I; Guo ZS; Chen GA; Weiser TS; Nguyen DM; Schrump DS
    Cancer Res; 1999 Dec; 59(24):6068-73. PubMed ID: 10626792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary approaches in the investigation and treatment of malignant pleural mesothelioma.
    Pass HI
    Chest Surg Clin N Am; 1994 Aug; 4(3):497-515. PubMed ID: 7953481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
    Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
    Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines.
    Pataer A; Smythe WR; Yu R; Fang B; McDonnell T; Roth JA; Swisher SG
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):61-7. PubMed ID: 11135160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of mesothelioma cell lines to adeno-associated virus 2 vector-based suicide gene therapy.
    Berlinghoff S; Veldwijk MR; Laufs S; Maser HP; Jauch A; Wenz F; Jens Zeller W; Fruehauf S
    Lung Cancer; 2004 Nov; 46(2):179-86. PubMed ID: 15474666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
    Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana.
    Schwarzenberger P; Harrison L; Weinacker A; Gaumer R; Theodossiou C; Summer W; Ye P; Marrogi AJ; Ramesh R; Freeman S; Kolls J
    J La State Med Soc; 1998 Apr; 150(4):168-74. PubMed ID: 9610071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.